Arent you being a little conservative Chand. LOL
I have it as 200 times on PE of 15!
1.2m x US$1125 = $1.35b X.38% = NP = A$641m (80c = US1)
300m shares at PE 15 = A$32
But remember we are only talking about ONE Bioeffective (in ONE country) - not the other 12 or so. And rememeber as well that long term BIO A is expected to be an income earner on equal footing as Ropren. Ah yes - the mind boggles!!